Sidley Austin is advising GlycoMimetics, Inc. on the transaction, and Gibson, Dunn & Crutcher is advising Crescent Biopharma, Inc. GlycoMimetics, Inc. (NASDAQ: GLYC) announced it has...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here